Email
Password
Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Connect
Log In Sign Up
Press Release

Prolastil E-50, a Botox Alternative Treatment Enhancing Skin Products Now Available to Consumers

PROLASTIL E-50 Scientific Update, has proven clinical studies by a research team at Thomas Jefferson University Medical School, the effectiveness of Prolastil for lasting enhancement in appearance of aging skin, using a face cream and eye serum.
RED BANK, NJ, June 05, 2012 /24-7PressRelease/ -- Newly marketed under the brand name Prolastil, Prolastil-E50 products produced remarkable results when clinically studied for improvement in fine lines and wrinkles. Long considered almost impossible, the product uses the scientific advancement of recombinant DNA, to produce laboratory grade human sh-polypeptide 50 which, when applied to the skin twice a day, increases the elasticity of the skin by replacing the elastin the skin stops producing by puberty. Previously it was thought that the molecules were too large to have a chance to bind with skin, however, new research has shown that once the DNA sequence of elastin was deciphered, it was possible to develop a skin care product that actually did affect aged skin. The clinical results have been released at www.Prolastil.com.
The products, both Prolastil Face cream and Prolastil Eye Serum are marketed thru physician offices and exclusive skin spas. The company is actively recruiting reps for distribution of their products nationwide.
for more information you may contact info@prolastil.com.
We now have formidable evidence that a proprietary formulation of Sh-polypeptide 50, the laboratory grade, active ingredient in Prolastil E-50 can affect the loss of elastin thru the aging process. This is essential for reducing a sagging appearance, and rejuvenating skin. Prolastil is widely used with other cosmetic procedures such as Botox treaments, Restylane, Juvederm,Laser, and many other treatments.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Latest News
Top News
Engage

Corporate

Help & Support

News Links

copyright © 2014 digitaljournal.com   |   powered by dell servers